NCT07047222

Brief Summary

This study evaluated the effectiveness of a Behavior Change Communication (BCC) intervention in improving menstrual health among female university students in Bangladesh. The intervention focused on three outcomes: dysmenorrhea, premenstrual syndrome (PMS), and menstrual irregularity (MI), promoting a non-pharmacological, sustainable approach through behavioral and lifestyle changes. Three structured educational sessions on menstrual health, healthy diet, and physical activity were delivered by trained female educators between May 20 and June 30, 2023, at Patuakhali Science and Technology University, Barishal University, and Khulna University. Participation was voluntary. Reinforcement follow-ups were conducted every two months for six months. A quasi-experimental design was employed. Post-intervention data were collected from February to March 2024. Based on sample size calculations assuming a 30% reduction in disorder prevalence, 498 students (249 per group) were initially enrolled. After exclusions, 234 intervention and 238 control participants were analyzed for dysmenorrhea; 228 per group for PMS and MI. Propensity score matching (1:1, caliper 0.01, no replacement) yielded 98 matched participants per group for final analysis. Eligible participants were female students aged ≥19 years, residing in university dormitories. Data collection used validated Bengali-language, interviewer-administered questionnaires, based on relevant literature and menstrual health IEC materials. Trained female enumerators ensured data quality and participant comfort. Primary outcomes were: (1) Dysmenorrhea, measured by the Andersch and Milsom score (dichotomized Yes/No); (2) PMS, assessed using the Premenstrual Symptoms Screening Tool, with no/mild PMS and moderate to severe PMS/PMDD as the outcome; (3) MI, defined as self-reported menstrual cycles \<21 or \>35 days. The treatment variable was BCC exposure (Yes/No). Covariates included physical activity, BMI, dietary diversity (DDS ≥5), food cravings, breakfast skipping, sleep duration, caffeine use, bedtime, family history of menstrual disorders, age at menarche, marital status, residence, and parental education and occupation. Baseline differences were assessed using descriptive statistics, chi-square, and t-tests. Conditional logistic regression estimated intervention effects on matched data. Sensitivity analyses (ATE, ATT, balance diagnostics, Bayesian logistic regression) supported the robustness of results.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
498

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 8, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
Last Updated

July 2, 2025

Status Verified

June 1, 2025

Enrollment Period

11 months

First QC Date

June 8, 2025

Last Update Submit

June 27, 2025

Conditions

Keywords

Menstrual HealthMenstrual disordersBehavior Change CommunicationLifestyle InterventionFemale University StudentsBCC ModuleDietary DiversityPhysical ActivityBangladeshPropensity Score Matching (PSM)

Outcome Measures

Primary Outcomes (3)

  • Prevalence of Dysmenorrhea

    Dysmenorrhea pain was evaluated using a four-point grading scale that assessed both the severity of pain and its interference with the daily activities: Grade 0 indicated no pain, Grade 1 mild pain, Grade 2 moderate pain, and Grade 3 severe pain. For analytical purposes, this scale was dichotomized into a binary variable, where "0" represented the absence of pain (Grade 0), and "1" indicated the presence of any level of pain (Grades 1 to 3: mild, moderate, or severe).

    Participants received three BCC sessions over approximately 6 weeks, followed by regular support to encourage behavior change for up to 6 months, with monitoring every two months. Final outcomes were assessed about 8 months after enrollment.

  • Prevalence of Premenstrual syndrome (PMS)

    Premenstrual symptoms were assessed using premenstrual symptoms screening tool (PSST) and categorized into three groups: No/Mild PMS, Moderate to Severe PMS, and premenstrual dysphoric disorder (PMDD). For analysis, these were combined into a binary variable: 0 = No/Mild PMS and 1 = Moderate to Severe PMS or PMDD

    Each participant received three BCC sessions over 6 weeks, followed by behavior change support and follow-up for 6 months. The final outcome evaluation was performed approximately 8 months after enrollment.

  • Prevalence of Menstrual Irregularity (MI)

    Menstrual cycle irregularity was assessed based on participants' self-reported cycle lengths. A cycle was considered irregular (coded 1 = Yes) if it was shorter than 21 days or longer than 35 days. Cycles within the 21-35 day range were classified as not irregular (coded 0 = No)

    Each participant completed the BCC sessions over approximately 6 weeks and followed by 6 months of support to encourage behavior change. The outcomes were assessed about 8 months after enrollment.

Study Arms (2)

Intervention group

EXPERIMENTAL

Female university students who voluntarily registered for the structured BCC module formed the intervention group. The module comprised three interactive sessions that combined educational presentations, yoga demonstrations, distribution of informative pamphlets, quiz-based learning, and the provision of small rewards to encourage active engagement. To support lasting behavior change and address any ongoing challenges, follow-up sessions were conducted every two months.

Behavioral: Behavioral change communication (BCC) module

Control group

NO INTERVENTION

The Control group consisted of female students from the same universities who did not receive any educational session of BCC module or follow-up during the intervention period. They were selected using student dormitory records and matched to the intervention group through propensity score matching to ensure comparability. As they did not receive any form of intervention, this group served as the matched comparison group for evaluating the effectiveness of the BCC module on menstrual health outcomes.

Interventions

The behavior change communication (BCC) module was designed to enhance awareness and promote effective management of menstrual disorders through structured lifestyle and behavioral guidance. It consisted of three 1-hour sessions: (1) education on menstrual disorders and related risk factors; (2) healthy dietary practices; and (3) physical activity (including yoga) and other lifestyle improvements. Sessions were held from May 20 to June 30, 2023, at three public universities in Bangladesh and were delivered by trained female educators. All session dates were approved by university authorities. Activities included interactive presentations, yoga demonstrations, pamphlet distribution, quizzes, and gift giveaways. To reinforce and support behavior change, follow-up visits were conducted every two months from July 15, 2023, to January 15, 2024.

Also known as: BCC module
Intervention group

Eligibility Criteria

Age19 Years - 25 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female university students aged 19 to 25 years, based on self-reported age, verified through enrollment records. The young adult female of this age range was selected to capture reproductive-aged participants most likely to experience menstrual disorders.
  • Currently enrolled as full-time undergraduate students at one of the following selected public universities in Bangladesh: Patuakhali Science and Technology University (PSTU), Barisal University (BU), or Khulna University (KU). These institutions were selected based on logistical feasibility and representativeness of the target population.
  • Willing and able to provide written informed consent after being fully informed of the study's purpose, procedures, potential risks, and benefits, and their rights as participants. Informed consent was obtained in accordance with ethical guidelines of SUST Research Ethics Board (SREB).
  • Available and committed to participating in all phases of the study, including all three intervention sessions (BCC module), bimonthly follow-up over a six-month period (July 2023 to January 2024) and in evaluation of the intervention's effectiveness.
  • Have regular access to a mobile phone, email, or another reliable means of communication to receive reminders, updates, and follow-up contacts related to intervention sessions and data collection.
  • Able to comprehend and respond to study instructions and questionnaires in either Bengali or English, ensuring accurate data collection and meaningful engagement in the intervention.
  • Not currently pregnant or breastfeeding, as confirmed during initial screening, to ensure hormonal stability and comparability across participants.

You may not qualify if:

  • Currently receiving treatment with hormonal contraceptives, hormone replacement therapy, or any other medication specifically prescribed to manage menstrual disorders (e.g., dysmenorrhea, premenstrual syndrome, or irregular menstrual cycle).
  • History of major abdominal or gynecological surgery (e.g., hysterectomy, oophorectomy, or myomectomy) that may affect menstrual function or reproductive physiology.
  • Clinical diagnosis of chronic gynecological conditions, including but not limited to polycystic ovary syndrome (PCOS), endometriosis, or uterine fibroids.
  • Diagnosed with chronic endocrine disorders such as thyroid disease, adrenal disorders, or diabetes mellitus, which may affect menstrual health.
  • Pregnant, planning to conceive, or currently breastfeeding at the time of enrollment.
  • Participation in another clinical trial or intervention study related to reproductive health, dietary habit, or physical activity.
  • Presence of any diagnosed psychiatric illness or cognitive impairment that could interfere with participation in educational sessions or accurate reporting of menstrual symptoms.
  • Refusal or inability to provide informed consent or commit to the follow-up schedule.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Patuakhali Science and technology University

Dumki, Patuakhali, 8602, Bangladesh

Location

Related Publications (10)

  • Mitsuhashi R, Sawai A, Kiyohara K, Shiraki H, Nakata Y. Factors Associated with the Prevalence and Severity of Menstrual-Related Symptoms: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 Dec 29;20(1):569. doi: 10.3390/ijerph20010569.

    PMID: 36612891BACKGROUND
  • Hanley-Cook GT, Tung JYA, Sattamini IF, Marinda PA, Thong K, Zerfu D, Kolsteren PW, Tuazon MAG, Lachat CK. Minimum Dietary Diversity for Women of Reproductive Age (MDD-W) Data Collection: Validity of the List-Based and Open Recall Methods as Compared to Weighed Food Record. Nutrients. 2020 Jul 9;12(7):2039. doi: 10.3390/nu12072039.

    PMID: 32659995BACKGROUND
  • WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 Jan 10;363(9403):157-63. doi: 10.1016/S0140-6736(03)15268-3.

    PMID: 14726171BACKGROUND
  • Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput JP, Chastin S, Chou R, Dempsey PC, DiPietro L, Ekelund U, Firth J, Friedenreich CM, Garcia L, Gichu M, Jago R, Katzmarzyk PT, Lambert E, Leitzmann M, Milton K, Ortega FB, Ranasinghe C, Stamatakis E, Tiedemann A, Troiano RP, van der Ploeg HP, Wari V, Willumsen JF. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.

    PMID: 33239350BACKGROUND
  • Ansong E, Arhin SK, Cai Y, Xu X, Wu X. Menstrual characteristics, disorders and associated risk factors among female international students in Zhejiang Province, China: a cross-sectional survey. BMC Womens Health. 2019 Feb 18;19(1):35. doi: 10.1186/s12905-019-0730-5.

    PMID: 30777053BACKGROUND
  • Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003 Aug;6(3):203-9. doi: 10.1007/s00737-003-0018-4.

    PMID: 12920618BACKGROUND
  • Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol. 1982 Nov 15;144(6):655-60. doi: 10.1016/0002-9378(82)90433-1.

    PMID: 7137249BACKGROUND
  • Sen LC, Jahan I, Salekin N, Shourove JH, Rahman M, Uddin MJ, Zhang C, H Hamer D, Islam GMR. Food craving, vitamin A, and menstrual disorders: A comprehensive study on university female students. PLoS One. 2024 Sep 25;19(9):e0310995. doi: 10.1371/journal.pone.0310995. eCollection 2024.

    PMID: 39321166BACKGROUND
  • Slap GB. Menstrual disorders in adolescence. Best Pract Res Clin Obstet Gynaecol. 2003 Feb;17(1):75-92. doi: 10.1053/ybeog.2002.0342.

    PMID: 12758227BACKGROUND
  • Rupe ER, Rodean J, Hurley EA, Miller MK, Boncoeur MD, Masonbrink AR. Menstrual health among adolescents and young adults in rural Haiti. Reprod Health. 2022 Dec 20;19(1):227. doi: 10.1186/s12978-022-01533-4.

    PMID: 36539795BACKGROUND

MeSH Terms

Conditions

DysmenorrheaPremenstrual SyndromeMenstruation DisturbancesMotor Activity

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and SymptomsBehavior

Study Officials

  • GM Rabiul Islam, PhD

    Shahjalal University of Science and Technology Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
This was a quasi-experimental study with non-random recruitment conducted through campus outreach and voluntary registration. Interested students who wished to participate in BCC module were invited to register by providing their name, contact number, room number, residence name, and university. To form the control group, an equal number of students from the same residences who did not participate in the BCC sessions were identified and listed. Since participation in the intervention was voluntary and based on personal interest, random sampling was neither feasible nor aligned with the study objectives. Therefore, participants were selected using purposeful, non-random sampling based on their characteristics and willingness to participate.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The BCC module aimed to enhance awareness and promote effective management of menstrual disorders through structured guidance on lifestyle and behavioral changes. It included three sessions: the first covered menstrual disorders and their associated risk factors, the second focused on dietary habits, and the third addressed physical activity (including yoga) and other lifestyle factors. Sessions were conducted from May 20 to June 30, 2023, at PSTU, BU, and KU in Bangladesh by two trained female educators. Informed consent was obtained from interested participants. Session dates were approved by university authorities and included presentations, yoga demonstrations, pamphlet distribution, quizzes, and gifts. Participants were followed up every two months from July 15, 2023, to January 15, 2024, to support behavior change. A quasi-experimental post-evaluation (Feb-Mar 2024) used dormitory records and propensity score matching to compare outcomes with a control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator (PI) of the study

Study Record Dates

First Submitted

June 8, 2025

First Posted

July 2, 2025

Study Start

May 20, 2023

Primary Completion

March 31, 2024

Study Completion

March 31, 2024

Last Updated

July 2, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) underlying the primary findings published from this study will be made available to qualified academic or public health researchers upon reasonable request. Shared data will include demographic characteristics and post-intervention outcomes on menstrual health (e.g., dysmenorrhea, premenstrual symptoms, irregular menstrual cycle); socio-demographic variables (e.g., age at menarche, residence, marital status, parental education/occupation, family history of menstrual disorders); lifestyle factors (e.g., physical activity, BMI, dietary diversity, food cravings, caffeine intake, sleep, bedtime); and group assignment (intervention vs. control). Associated data dictionaries and coding manuals will be provided. The IPD will be fully de-identified in accordance with data protection standards to ensure participant confidentiality. The goal is to support reproducibility, meta-analyses, and further research on menstrual health interventions.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
De-identified IPD will become available 6 months after publication of this study results in a peer-reviewed journal and will remain accessible for a duration of 3 years. During this availability period, qualified researchers affiliated with academic, governmental, or non-profit public health institutions may request access to the dataset to verify findings, conduct secondary analyses, or contribute to meta-analyses focused on menstrual health outcomes (e.g., dysmenorrhea, PMS, irregular menstrual cycles) among young adult female populations.
Access Criteria
Qualified researchers may request access to the data for academic, non-commercial purposes. Requests must include a detailed research proposal and will be reviewed by the principal investigator and ethics committee. Access will be granted only if the proposal is methodologically sound, aligns with the original consent, and ensures participant confidentiality. Approved researchers must sign a data use agreement to protect participant privacy and comply with all ethical and legal data use requirements.

Locations